Chemoinformaics analysis of 2, 4, 5, 7 tetramethyloctane
Molecular Weight | 170.34 | nRot | 4 |
Heavy Atom Molecular Weight | 144.132 | nRig | 0 |
Exact Molecular Weight | 170.203 | nRing | 0 |
Solubility: LogS | -6.25 | nHRing | 0 |
Solubility: LogP | 5.761 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 37.3766 |
nHD | 0 | BPOL | 26.0834 |
QED | 0.583 |
Synth | 3.161 |
Natural Product Likeliness | 0.374 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.164 |
Pgp-sub | 0 |
HIA | 0.018 |
CACO-2 | -4.335 |
MDCK | 0.0000101 |
BBB | 0.734 |
PPB | 0.976774 |
VDSS | 3.546 |
FU | 0.0348559 |
CYP1A2-inh | 0.468 |
CYP1A2-sub | 0.848 |
CYP2c19-inh | 0.474 |
CYP2c19-sub | 0.939 |
CYP2c9-inh | 0.464 |
CYP2c9-sub | 0.846 |
CYP2d6-inh | 0.014 |
CYP2d6-sub | 0.36 |
CYP3a4-inh | 0.356 |
CYP3a4-sub | 0.305 |
CL | 9.844 |
T12 | 0.203 |
hERG | 0.026 |
Ames | 0.007 |
ROA | 0.066 |
SkinSen | 0.261 |
Carcinogencity | 0.041 |
EI | 0.985 |
Respiratory | 0.216 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.528212 |